[Federal Register Volume 66, Number 238 (Tuesday, December 11, 2001)]
[Notices]
[Page 64063]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-30490]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (01-156)]


Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of prospective patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice that The Texas A&M University System, 
having offices in College Station, Texas, has applied for a partially 
exclusive license to practice the inventions described and claimed in 
U.S. Patent No. 5,827,531, entitled ``Multi-Lamellar, Immiscible-Phase 
Microencapsulation of Drugs''; U.S. Patent No. 6,099,864, entitled 
``INSITU Activation of Microcapsules''; U.S. Patent No. 6,214,300, 
entitled ``Microencapsulation and Electrostatic Processing Device 
(MEPS)''; U.S. Patent No. 6,103,271, entitled ``Microencapsulation & 
Electrostatic Coating Process''; pending U.S. Patent Application 
entitled ``Protein Crystal Encapsulation Process''; NASA Case No. 
MSC22936-1-SB; pending U.S. Patent Application entitled ``Externally 
Triggered Microcapsules''; NASA Case No. MSC 22939-1-SB and pending 
continuations, divisional applications, and foreign applications 
corresponding to the above-listed cases. Each of the above-listed 
patents and patent applications are assigned to the United States of 
America as represented by the Administrator of the National Aeronautics 
and Space Administration. With respect to U.S. Patent No. 5,827,531 
only. NASA's property interests are presently limited by the terms of 
previously issued License No. DE-252. NASA is in the process of 
terminating the DE-252 License, pursuant to the terms of that license 
and applicable provisions of Title 37 of the Code of Federal 
Regulations, part 404. Written objections to the prospective grant of a 
license should be sent to the Johnson Space Center.

DATES: Responses to this notice must be received by January 10, 2002.

FOR FURTHER INFORMATION CONTACT: James Cate, Patent Attorney, NASA 
Johnson Space Center, Mail Stop HA, Houston, TX 77058-8452; telephone 
(281) 483-1001.

    Dated: December 4, 2001.
Robert M. Stephens,
Deputy General Counsel.
[FR Doc. 01-30490 Filed 12-10-01; 8:45 am]
BILLING CODE 7510-01-P